February 28, 2013
February 28 is Rare Disease Day — a concept first initiated by the European Rare Disease Organization (EURORDIS) and now recognized around the world. Around 6,800 rare diseases have been identified and up to 80% of them have a genetic origin. 23andMe provides genetic health reports for many of these [...]
December 6, 2012
Earlier this year we met our goal of enrolling 1,000 people in a community of people with a collection of rare blood disorders known as myeloproliferative neoplasms, or MPNs. Since then we’ve been able to replicate known genetic associations with these rare disorders, as well as make new findings of our [...]
October 12, 2012
Dave Hinds is a Principal Scientist in Statistical Genetics. 23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these disorders consider them to be blood cancers, though individual prognoses can vary widely — some [...]
October 1, 2012
Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research [...]
September 4, 2012
Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the [...]
May 21, 2012
23andMe is passionate about fighting cancer. We’re researching specific forms of cancer and treatments (see sidebar) and also learning more generally about cancer through our Cancer Family History survey (men’s version and women’s version). Personal experiences have the potential to fuel important [...]
May 11, 2012
Cancer is not one disease, but many. Even looking specifically at breast cancer or sarcoma, the more researchers study these diseases, the more they understand that there are many different kinds of breast cancer and sarcoma. This has been one of the most challenging aspects of researching cures for [...]
March 21, 2012
Like many people around the world, the health content team at 23andMe rang in 2012 with resolutions of staying healthy and it seemed fitting to delve into the genetics underlying response to diet and exercise, eating behavior and cholesterol levels. As we eased in to the new year, we segued into reproduction, [...]
March 9, 2012
In August of last year, I wrote with hope and excitement about the launch of the 23andMe MPN Research Initiative because my father, Harvey, suffers from myelofibrosis. On March 5, 23andMe scientist Bethann Hromatka posted a SNPWatch report about the association between the JAK2 gene and MPNs. 23andMe [...]
March 7, 2012
Luck is not the word you typically associate with a cancer diagnosis or even a heightened risk of cancer, but some people can see a silver lining even in the darkest storms. Harvey Gould and John Lauerman certainly have. “Some believe that blessings come out of serious adversity,” said Harvey, who [...]
